AI assistant
Sending…
ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021
Dec 1, 2021
32811_dirs_2021-12-01_ec89cbee-4ae0-47cc-b27a-94e1c168c5bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-12-01
Reporting Person: Plooster Matthew R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-01 | Common Stock | A | 2500 | $8.44 | Acquired | 2500 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1532 | Direct |
| Common Stock | 69 | Indirect |
Footnotes
F1: Held jointly with spouse.
More from ZEVRA THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 20
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2